Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mark Chin Insider Profile
11 Followers
Mark Chin, Director at Iterum Therapeutics, holds 0.00 shares in Harpoon Therapeutics (Ticker: HARP), holds 18.31K shares in Iterum Therapeutics (Ticker: ITRM), holds 0.00 shares in Pyxis Oncology (Ticker: PYXS).
Profitable Transactions
3 out of 8 Profitable Transactions
Average Return
-26.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Mark Chin holds in companies
Most Profitable Insider Trade
Stock:
Harpoon Therapeutics
(HARP)
(HARP)
Rating:Informative Sell
Date:Dec 10, 2019 - Dec 10, 2020
Return:+21.80%
The most profitable trade made by Mark Chin
Mark Chin's Trading History
Iterum Therapeutics
Jun 15, 2023
Director
Uninformative Buy
17.60K
$27.83K
Harpoon Therapeutics
Mar 11, 2024
―
Uninformative Sell
―
$0.00
Enliven Therapeutics
Jul 28, 2021
Director
Informative Buy
8.00M
$61.37M
Pyxis Oncology
Apr 25, 2022
Former Director
Informative Sell
5.32M
$0.00
Disc Medicine
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Mark Chin's performance on stock
You May Also Like
Mark Chin insider profile FAQ
What is the percentage of profitable transactions made by Mark Chin?
The percentage of profitable transactions made by Mark Chin is 38%.
What is the average return per transaction made by Mark Chin?
The average return per transaction made by Mark Chin is -26.40%.
What stocks does Mark Chin hold?
Mark Chin holds: ITRM, HARP, ELVN, PYXS, IRON stocks.
What was Mark Chin’s latest transaction?
Mark Chin latest transaction was an Uninformative Sell of ―.
What was Mark Chin's most profitable transaction?
Mark Chin’s most profitable transaction was an Informative Sell of HARP stock on December 10, 2019. The return on the trade was 21.80%.
What is Mark Chin's role in Iterum Therapeutics?
Mark Chin's role in Iterum Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.